In bladder cancer, the T24 human transitional carcinoma cell line produces IDO constitutively in culture [24], even without involvement of the immune system, leading to the hypothesis that IDO may have a role in non-immune processes. The gene discussed is IDO1; the disease is urinary bladder cancer.